A citation-based method for searching scientific literature

J Kellogg Parsons, David Zahrieh, James L Mohler, Electra Paskett, Donna E Hansel, Adam S Kibel, Heshan Liu, Drew K Seisler, Loki Natarajan, Martha White, Olwen Hahn, John Taylor, Sheri J Hartman, Sean P Stroup, Peter Van Veldhuizen, Lannis Hall, Eric J Small, Michael J Morris, John P Pierce, James Marshall. JAMA 2020
Times Cited: 8







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A dietary intervention for recurrent prostate cancer after definitive primary treatment: results of a randomized pilot trial.
James Carmody, Barbara Olendzki, George Reed, Victoria Andersen, Penny Rosenzweig. Urology 2008
35
37

Intensive lifestyle changes may affect the progression of prostate cancer.
Dean Ornish, Gerdi Weidner, William R Fair, Ruth Marlin, Elaine B Pettengill, Caren J Raisin, Stacey Dunn-Emke, Lila Crutchfield, F Nicholas Jacobs, R James Barnard,[...]. J Urol 2005
218
37

Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled Trial.
Frank Stenner-Liewen, Heike Liewen, Richard Cathomas, Christoph Renner, Ulf Petrausch, Tullio Sulser, Katharina Spanaus, Hans Helge Seifert, Räto Thomas Strebel, Alexander Knuth,[...]. J Cancer 2013
24
37

Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.
Jill M Hamilton-Reeves, Snigdha Banerjee, Sushanta K Banerjee, Jeffrey M Holzbeierlein, J Brantley Thrasher, Suman Kambhampati, John Keighley, Peter Van Veldhuizen. PLoS One 2013
34
25

Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.
Nagi B Kumar, Loveleen Kang, Julio Pow-Sang, Ping Xu, Kathy Allen, Diane Riccardi, Karen Besterman-Dahan, Jeffrey P Krischer. J Soc Integr Oncol 2010
17
25

The specific role of isoflavones in reducing prostate cancer risk.
Nagi B Kumar, Alan Cantor, Kathy Allen, Diane Riccardi, Karen Besterman-Dahan, John Seigne, Mohamad Helal, Raoul Salup, Julio Pow-Sang. Prostate 2004
85
25

Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Leslie Fischer, Chrysa Mahoney, A Robert Jeffcoat, Matthew A Koch, Brian E Thomas, John L Valentine, Thomas Stinchcombe, Jarol Boan, James A Crowell, Steven H Zeisel. Nutr Cancer 2004
69
25

Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.
Jason Gee, Howard Bailey, Kyungmann Kim, Jill Kolesar, Tom Havighurst, Kendra D Tutsch, William See, Michael B Cohen, Nick Street, Leon Levan,[...]. Prostate 2013
26
25

Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled study.
Ries Kranse, Pieter C Dagnelie, Monique C van Kemenade, Frank H de Jong, Jan H M Blom, Lilian B M Tijburg, Jan A Weststrate, Fritz H Schröder. Int J Cancer 2005
39
25

Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
Ralph W deVere White, Robert M Hackman, Stephanie E Soares, Laurel A Beckett, Yueju Li, Buxiang Sun. Urology 2004
80
25

Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
Fabien S Dalais, Andreanyta Meliala, Naiyana Wattanapenpaiboon, Mark Frydenberg, David A I Suter, William K Thomson, Mark L Wahlqvist. Urology 2004
81
25

A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.
Stephen J Freedland, Michael Carducci, Nils Kroeger, Alan Partin, Jian-Yu Rao, Yusheng Jin, Susan Kerkoutian, Hong Wu, Yunfeng Li, Patricia Creel,[...]. Cancer Prev Res (Phila) 2013
30
25

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
Freddie C Hamdy, Jenny L Donovan, J Athene Lane, Malcolm Mason, Chris Metcalfe, Peter Holding, Michael Davis, Tim J Peters, Emma L Turner, Richard M Martin,[...]. N Engl J Med 2016
25

Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation.
Mark Jesus M Magbanua, Ritu Roy, Eduardo V Sosa, Vivian Weinberg, Scott Federman, Michael D Mattie, Millie Hughes-Fulford, Jeff Simko, Katsuto Shinohara, Christopher M Haqq,[...]. PLoS One 2011
32
25

Mediterranean dietary pattern and the risk of prostate cancer: A meta-analysis.
Sheng Cheng, Qiming Zheng, Guoqing Ding, Gonghui Li. Medicine (Baltimore) 2019
6
33

Diet and lifestyle considerations for patients with prostate cancer.
Kyle B Zuniga, June M Chan, Charles J Ryan, Stacey A Kenfield. Urol Oncol 2020
4
50


Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA.
Ingvild Paur, Wolfgang Lilleby, Siv Kjølsrud Bøhn, Erik Hulander, Willibrord Klein, Ljiljana Vlatkovic, Karol Axcrona, Nils Bolstad, Trine Bjøro, Petter Laake,[...]. Clin Nutr 2017
21
25

Selenium supplementation and prostate cancer mortality.
Stacey A Kenfield, Erin L Van Blarigan, Natalie DuPre, Meir J Stampfer, Edward L Giovannucci, June M Chan. J Natl Cancer Inst 2014
32
25

Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.
Mary K Downer, Stacey A Kenfield, Meir J Stampfer, Kathryn M Wilson, Barbra A Dickerman, Edward L Giovannucci, Eric B Rimm, Molin Wang, Lorelei A Mucci, Walter C Willett,[...]. J Clin Oncol 2019
11
25

Nutritional aspects of prostate cancer: a review.
A J Blumenfeld, N Fleshner, B Casselman, J Trachtenberg. Can J Urol 2000
27
12

Chemoprevention of prostate cancer: concepts and strategies.
G J Kelloff, R Lieberman, V E Steele, C W Boone, R A Lubet, L Kopelovitch, W A Malone, J A Crowell, C C Sigman. Eur Urol 1999
74
12

Plant Bioactives and the Prevention of Prostate Cancer: Evidence from Human Studies.
Tracey L Livingstone, Gemma Beasy, Robert D Mills, Jenny Plumb, Paul W Needs, Richard Mithen, Maria H Traka. Nutrients 2019
8
12

Estrogens and mechanisms of prostate cancer progression.
Giuseppe Carruba. Ann N Y Acad Sci 2006
45
12

Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens.
N R Mucci, M A Rubin, M S Strawderman, J E Montie, D C Smith, K J Pienta. J Natl Cancer Inst 2000
27
12

Absorption and excretion of the soy isoflavone genistein in rats.
R A King, J L Broadbent, R J Head. J Nutr 1996
107
12

Knowledge and use of finasteride for the prevention of prostate cancer.
Robert J Hamilton, Leila C Kahwati, Linda S Kinsinger. Cancer Epidemiol Biomarkers Prev 2010
19
12



Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry.
Shrruti K Grover, Sarla Agarwal, Sanjay Gupta, Neelam Wadhwa, Nivedita Sharma. Pathol Oncol Res 2015
5
20


Chemoprevention strategies in the prostate: an overview.
Gary J Kelloff, Howard R Higley, Michael K Brawer, M Scott Lucia, Caroline C Sigman, E David Crawford. Rev Urol 2002
7
14

Subsequent prostate cancer detection in patients with prostatic intraepithelial neoplasia or atypical small acinar proliferation.
Moamen M Amin, Suganthiny Jeyaganth, Nader Fahmy, Louis Bégin, Samuel Aronson, Stephen Jacobson, Simon Tanguay, Armen G Aprikian. Can Urol Assoc J 2007
23
12

Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.
Kyung Seok Han, In Gab Jeong, Jea Young Joung, Seung Ok Yang, Jinsoo Chung, Ho Kyung Seo, Weon Seo Park, Kang Hyun Lee. Urology 2007
11
12

Soy isoflavones and prostate cancer: a review of molecular mechanisms.
Abeer M Mahmoud, Wancai Yang, Maarten C Bosland. J Steroid Biochem Mol Biol 2014
125
12

Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis.
T Fotsis, M Pepper, H Adlercreutz, T Hase, R Montesano, L Schweigerer. J Nutr 1995
174
12

Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Giuseppe Pandini, Rossana Mineo, Francesco Frasca, Charles T Roberts, Marco Marcelli, Riccardo Vigneri, Antonino Belfiore. Cancer Res 2005
139
12

Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Srilatha Swami, Aruna V Krishnan, Jacqueline Moreno, Rumi S Bhattacharyya, Christopher Gardner, James D Brooks, Donna M Peehl, David Feldman. Int J Cancer 2009
34
12

Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Jennifer D Wu, Kathy Haugk, Libby Woodke, Peter Nelson, Ilsa Coleman, Stephen R Plymate. J Cell Biochem 2006
117
12

Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue.
Leonard S Marks, Munekado Kojima, Angelo Demarzo, David Heber, David G Bostwick, Junqi Qian, Frederick J Dorey, Robert W Veltri, James L Mohler, Alan W Partin. Urology 2004
27
12

Role of diet in prostate cancer development and progression.
June M Chan, Peter H Gann, Edward L Giovannucci. J Clin Oncol 2005
227
12

Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.
Aslamuzzaman Kazi, Kenyon G Daniel, David M Smith, Nagi B Kumar, Q Ping Dou. Biochem Pharmacol 2003
99
12




A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Debra L Bemis, Jillian L Capodice, Manisha Desai, Ralph Buttyan, Aaron E Katz. Clin Cancer Res 2004
48
12

Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.
Oleksandr N Kryvenko, Michelle Jankowski, Dhananjay A Chitale, Deliang Tang, Andrew Rundle, Sheri Trudeau, Benjamin A Rybicki. Mod Pathol 2012
42
12

Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.
Alexandre R Zlotta, Shin Egawa, Dmitry Pushkar, Alexander Govorov, Takahiro Kimura, Masahito Kido, Hiroyuki Takahashi, Cynthia Kuk, Marta Kovylina, Najla Aldaoud,[...]. J Natl Cancer Inst 2013
125
12

Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
J Kellogg Parsons, H Ballentine Carter, Elizabeth A Platz, E James Wright, Patricia Landis, E Jeffrey Metter. Cancer Epidemiol Biomarkers Prev 2005
106
12

Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men.
Marjorie G Busby, A Robert Jeffcoat, LeAnne T Bloedon, Matthew A Koch, Tracy Black, Kelly J Dix, William D Heizer, Brian F Thomas, Judith M Hill, James A Crowell,[...]. Am J Clin Nutr 2002
181
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.